Monogram Biosciences, Inc.

Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus HIV infection, hepatitis C virus HCV infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype/genotype assays, as well as suppression management and viral load testing; HCV assays; and oncology tests. The company also provides biopharmaceutical partners and research collaborators with clinical, scientific, and logistical support for critical drug development projects in HIV infection, HCV infection, and oncology via agreements, strategic alliances, and long-term partnerships. Monogram Biosciences, Inc. was formerly known as ViroLogic, Inc. and changed its name to Monogram Biosciences, Inc. in September 2005. The company was incorporated in 1995 and is headquartered in South San Francisco, California. As of August 3, 2009, Monogram Biosciences, Inc. operates as a subsidiary of Laboratory Corporation of America Holdings.